It was shown that CD62+ EVs counts were higher in MI patients with diabetes, and patients with hypertension had increased levels of CD14+ EVs, whereas the higher concentrations of CD62+ EVs early after MI were associated with an increased risk of cardiovascular events during follow up. This evidence concerns the gene SELP and hypertensive disorder.